Registration & access
Putting new tools in motion
DNDi’s commitment to the health and well-being of neglected patients guides everything we do, including our work to ensure equitable and affordable access to the treatments we develop.
From our experience supporting the registration and introduction of nine new treatments so far, we have learned that the transition from approval of a new treatment to widespread patient access is one of the most challenging aspects of our mission.
A wide range of potential obstacles can block patients’ access to the treatments they need:
- New medicines may not be registered and approved for use in countries where they are needed
- Treatment guidelines may not be updated to include new medicines
- Medicines may be unaffordable for patients and health systems
- Manufacturing may be insufficient, and supply chains or service delivery systems may be weak
- Diagnosis and treatment may be unavailable where patients seek care, or clinicians may not be trained in their use
No organization can address complex access challenges like these alone – and the challenges can vary widely for different products, market conditions, diseases, and settings. We work from the very beginning of the R&D process to ensure the treatments we develop reach patients in need, continuously identifying potential roadblocks and building the partnerships needed to overcome them.
Chagas disease: accelerating access to testing and treatment
We’re working to simplify testing and make treatment available closer to home for patients in a remote region of Colombia
Our strategic access priorities
DNDi’s access strategy relies on partnerships with health ministries, national control programmes, industrial partners, NGO allies, patient groups, and others to reach neglected patients and communities, and achieve maximum public health impact.
With several new treatments in late-stage development, we are laying the groundwork for treatment access in three main areas of intervention.
Get our latest news, personal stories, research articles, and job opportunities.